The study, International coverage of GLP-1 Receptor Agonists: A Review and Ethical Analysis of Discordant Approaches, was published on August 16, 2024 in the Lancet
The Future of Peptides: RFK Jr
The target is metabolic: insulin sensitivity, visceral and liver fat, lipids, the markers of metabolic health rather than a number on the scale
The FDA is not bound by the advisory committee's recommendations
If you are prescribed medication, you can work closely with your healthcare provider to determine your optimal dosing schedule and discuss any side effects you experience
Unfortunately, detecting a B12 deficiency isnt always straightforward, as the symptoms often overlap with other conditions